Product Recalls in Minnesota

Product recalls affecting Minnesota — including food, drugs, consumer products, medical devices, and vehicles distributed to Minnesota. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,698 recalls have been distributed to Minnesota in the last 12 months.

52,120 total recalls
2,698 in last 12 months

Showing 181200 of 13,424 recalls

DrugOctober 31, 2025· Blossom Pharmaceuticals

Recalled Item: Dynagel Recalled by Blossom Pharmaceuticals Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 31, 2025· Blossom Pharmaceuticals

Recalled Item: WeCare Recalled by Blossom Pharmaceuticals Due to cGMP deviations

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2025· Otsuka ICU Medical LLC

Recalled Item: POTASSIUM CHLORIDE Inj. Recalled by Otsuka ICU Medical LLC Due to Labeling:...

The Issue: Labeling: Label Error on Declared Strength-The overwrap label may...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 29, 2025· Otsuka ICU Medical LLC

Recalled Item: POTASSIUM CHLORIDE Inj. Recalled by Otsuka ICU Medical LLC Due to Labeling:...

The Issue: Labeling: Label Error on Declared Strength-The overwrap label may...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 28, 2025· Agebox

Recalled Item: Agebox iKids-Growth (Night Formula) Recalled by Agebox Due to Undeclared...

The Issue: Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 28, 2025· Agebox

Recalled Item: Agebox iKids-Growth (Day Formula) capsules Recalled by Agebox Due to...

The Issue: Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 28, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Lisdexamfetamine Dimesylate Capsules Recalled by SUN PHARMACEUTICAL...

The Issue: Failed Dissolution Specifications: An out of specification results observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 28, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Lisdexamfetamine Dimesylate Capsules Recalled by SUN PHARMACEUTICAL...

The Issue: Failed Dissolution Specifications: An out of specification results observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 28, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Lisdexamfetamine Dimesylate Capsules Recalled by SUN PHARMACEUTICAL...

The Issue: Failed Dissolution Specifications: An out of specification results observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 28, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Lisdexamfetamine Dimesylate Capsules Recalled by SUN PHARMACEUTICAL...

The Issue: Failed Dissolution Specifications: An out of specification results observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 28, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Lisdexamfetamine Dimesylate Capsules Recalled by SUN PHARMACEUTICAL...

The Issue: Failed Dissolution Specifications: An out of specification results observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 28, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Lisdexamfetamine Dimesylate Capsules Recalled by SUN PHARMACEUTICAL...

The Issue: Failed Dissolution Specifications: An out of specification results observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 28, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Lisdexamfetamine Dimesylate Capsules Recalled by SUN PHARMACEUTICAL...

The Issue: Failed Dissolution Specifications: An out of specification results observed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 27, 2025· Otsuka ICU Medical LLC

Recalled Item: 0.9% SODIUM CHLORIDE Injection Recalled by Otsuka ICU Medical LLC Due to...

The Issue: Lack of Assurance of Sterility: Potential for flexible container leaks.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 24, 2025· Cipla USA, Inc.

Recalled Item: Lanthanum Carbonate chewable tablets Recalled by Cipla USA, Inc. Due to...

The Issue: Failed stability specifications: Out of specification for hardness test

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 24, 2025· Cipla USA, Inc.

Recalled Item: Lanthanum Carbonate chewable tablets Recalled by Cipla USA, Inc. Due to...

The Issue: Failed stability specifications: Out of specification for hardness test

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Bromocriptine Mesylate Capsules Recalled by Zydus Pharmaceuticals (USA) Inc...

The Issue: Failed Impurities/Degradation Specifications: Out of Specification (OOS)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: clomiPRAMINE Hydrochloride Recalled by Zydus Pharmaceuticals (USA) Inc Due...

The Issue: cGMP deviations: an observed Out of Specification of Nitrosamine Drug...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: clomiPRAMINE Hydrochloride Recalled by Zydus Pharmaceuticals (USA) Inc Due...

The Issue: cGMP deviations: an observed Out of Specification of Nitrosamine Drug...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2025· Zydus Pharmaceuticals (USA) Inc

Recalled Item: clomiPRAMINE Hydrochloride Recalled by Zydus Pharmaceuticals (USA) Inc Due...

The Issue: cGMP deviations: an observed Out of Specification of Nitrosamine Drug...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund